This is a randomized, active-controlled, parallel-group, double-blind Phase II trial, of oral restorative microbiota therapy (RMT) or placebo combined with int…

Adenocarcinoma of LungLung Cancer

~Estimated

~$10 – $6,250

Masonic Cancer Center, University of MinnesotaNCT04105270

Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer

This study is an observational study of blood and tissue biomarkers. Investigators plan to evaluate the accuracy of lung cancer biomarkers found in the blood i…

Lung; NodeAdenocarcinoma of Lung

~Estimated

~$10 – $750

H. Lee Moffitt Cancer Center and Research InstituteNCT05665504

Phase 2

Phase II Trial of LP-300 in Combination With Carboplatin and Pemetrexed in Never Smoker Patients With Relapsed Advanced Primary Adenocarcinoma of the Lung After Treatment With Tyrosine Kinase Inhibitors (The HARMONIC Study)

The goal of this clinical trial is to determine clinical advantages for LP-300 in combination with carboplatin and pemetrexed in the never smoker patient popul…

Adenocarcinoma of LungCarcinoma, Non-Small-Cell Lung

~Estimated

~$10 – $8,750

Lantern Pharma Inc.NCT05456256